Page 70 - The lraternational Journal of the Royal Society of Thailand.indd

The International Journal of the Royal Society of Thailand
Volume XV-2023

Watcharapong Piyaphanee is an Associated Professor at the Department of Clinical
Tropical Medicine, Faculty of Tropical Medicine, Mahidol University. He is an internist
and a specialist in Travel Medicine. Dr. Piyaphanee is the co-founder of the only
Residency Training Program in Travel Medicine. His primary research area is in
travel medicine field such as malaria/dengue infection among travelers, travelers’

diarrhea, vaccine usages in travelers.

Lorenz von Seidlein has been working on global health for the last 25 years based in
West Africa, South Korea, East Africa, Australia and most recently Thailand where he
is employed by the Mahidol Oxford Research Unit. He is coordinating malaria
elimination projects in Asia and working on a project in East Africa to provide better

health through improved housing.

References

Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, et al.
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med
2012; 367: 2284- 2295.

Butler D. Malaria vaccine gives disappointing results. Nature 2012. https://doiorg/101038/
nature201211785.

Chandramohan D, Zongo I, Sagara I, Cairns M, Yerbanga RS, Diarra M, et al. Seasonal
Malaria Vaccination with or without Seasonal Malaria Chemoprevention.
N Engl J Med 2021; 385: 1005-1017.

Cohen S, McGregor I, Carrington S. Gamma-globulin and acquired immunity to human
malaria.

Nature 1961; 192: 733-737.

Collins KA, Snaith R, Cottingham MG, Gilbert SC, Hill AVS. Enhancing protective
immunity to malaria with a highly immunogenic virus-like particle vaccine.
Sci Rep 2017; 7: 46621.

Datoo MS, Natama HM, Some A, Bellamy D, Traore O, Rouamba T, et al. Efficacy and
immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years’
follow- up in children in Burkina Faso: a phase 1/2b randomised controlled

trial. Lancet Infect Dis 2022; 22: 1728-1736.
Datoo MS, Natama MH, Some A, Traore O, Rouamba T, Bellamy D, et al. Efficacy of a
low- dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal

administration to children in Burkina Faso: a randomised controlled trial.
Lancet 2021; 397: 1809-1818.

62 The First Licensed Malaria Vaccines: From RTS,S to R21